<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36567371</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1573-2630</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>International ophthalmology</Title><ISOAbbreviation>Int Ophthalmol</ISOAbbreviation></Journal><ArticleTitle>Assessment of early and long-COVID related retinal neurodegeneration with optical coherence tomography.</ArticleTitle><Pagination><StartPage>2073</StartPage><EndPage>2081</EndPage><MedlinePgn>2073-2081</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10792-022-02607-9</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">The aim of this study is to investigate short-term and long-term effects of coronovirus 19 disease (COVID-19) at inner and outer retinal layers of patients recovered from COVID-19 with Spectral Domain Optical Coherence Tomography (SD-OCT) and compare these to healthy subjects.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Twenty-seven patients recovered from COVID-19, and age- and gender-matched 27 healthy controls were included in this study. Macular and peripapillary retinal nerve fiber layer (RNFL), ganglion cell-inner plexiform layer (GCIPL), inner nuclear layer (INL), outer plexiform layer (OPL) and outer nuclear layer (ONL) were analyzed with SD-OCT 1 month (V<sub>1</sub> visit) and 12 months (V<sub>2</sub> visit) after negative result of reverse transcriptase-polymerase chain reaction test.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Macular RNFL thickness in outer ring was thinner at V<sub>1</sub> and V<sub>2</sub> visits than healthy control (p&#x2009;=&#x2009;0.049 and p&#x2009;=&#x2009;0.005). Central and inferonasal quadrants of peripapillary RNFL thicknesses were reduced at V<sub>1</sub> and V<sub>2</sub> visits compared to controls (p&#x2009;=&#x2009;0.001 and p&#x2009;=&#x2009;0.024 for V<sub>1</sub> visit; p&#x2009;=&#x2009;0.001 and p&#x2009;=&#x2009;0.006 for V<sub>2</sub> visit). Thinning in ONL thickness in inner ring was observed at V<sub>1</sub> and V<sub>2</sub> visits than healthy subjects (p&#x2009;=&#x2009;0.006 and p&#x2009;=&#x2009;0.001).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Subclinical localized changes in macular and peripapillary RNFL and outer nuclear layer were demonstrated in early and 12-months follow-up after COVID-19 recovery.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s), under exclusive licence to Springer Nature B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Da&#x11f; &#x15e;eker</LastName><ForeName>Esra</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0001-6230-5529</Identifier><AffiliationInfo><Affiliation>Ankara City Hospital Ophthalmology Department, Universiteler Mah. 1604. Cad. No 9 Bilkent, Ankara, Turkey. dr.esra.seker@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Erbah&#xe7;eci Timur</LastName><ForeName>&#x130;nci Elif</ForeName><Initials>&#x130;E</Initials><Identifier Source="ORCID">0000-0001-6514-3748</Identifier><AffiliationInfo><Affiliation>Ankara City Hospital Ophthalmology Department, Universiteler Mah. 1604. Cad. No 9 Bilkent, Ankara, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Int Ophthalmol</MedlineTA><NlmUniqueID>7904294</NlmUniqueID><ISSNLinking>0165-5701</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D041623" MajorTopicYN="Y">Tomography, Optical Coherence</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012165" MajorTopicYN="N">Retinal Ganglion Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009412" MajorTopicYN="N">Nerve Fibers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Neurodegeneration</Keyword><Keyword MajorTopicYN="N">Optical Coherence Tomography</Keyword><Keyword MajorTopicYN="N">Retina</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare no competing interests. The authors have no relevant financial or non-financial interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>25</Day><Hour>23</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>26</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36567371</ArticleId><ArticleId IdType="pmc">PMC9790812</ArticleId><ArticleId IdType="doi">10.1007/s10792-022-02607-9</ArticleId><ArticleId IdType="pii">10.1007/s10792-022-02607-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270&#x2013;273. doi: 10.1038/s41586-020-2012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2012-7</ArticleId><ArticleId IdType="pmc">PMC7095418</ArticleId><ArticleId IdType="pubmed">32015507</ArticleId></ArticleIdList></Reference><Reference><Citation>Bchetnia M, Girard C, Duchaine C, et al. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review of the current global status. J Infect Public Health. 2020;13(11):1601&#x2013;1610. doi: 10.1016/j.jiph.2020.07.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jiph.2020.07.011</ArticleId><ArticleId IdType="pmc">PMC7402212</ArticleId><ArticleId IdType="pubmed">32778421</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO COVID-19 dashboard. Available from: https://who.sprinklr.com/. Accessed March 5, 2022.</Citation></Reference><Reference><Citation>Gupta A, Madhavan MV, Sehgal K, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020;26(7):1017&#x2013;1032. doi: 10.1038/s41591-020-0968-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0968-3</ArticleId><ArticleId IdType="pubmed">32651579</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen L, Deng C, Chen X, et al. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study. Acta Ophthalmol. 2020;98(8):e951&#x2013;e959. doi: 10.1111/aos.14472.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/aos.14472</ArticleId><ArticleId IdType="pmc">PMC7276826</ArticleId><ArticleId IdType="pubmed">32421258</ArticleId></ArticleIdList></Reference><Reference><Citation>Dag Seker E, Erbahceci Timur IE. COVID-19: more than a respiratory virus, an optical coherence tomography study. Int Ophthalmol. 2021;41(11):3815&#x2013;3824. doi: 10.1007/s10792-021-01952-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10792-021-01952-5</ArticleId><ArticleId IdType="pmc">PMC8315248</ArticleId><ArticleId IdType="pubmed">34318370</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou X, Chen K, Zou J, et al. Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection. Front Med. 2020;14(2):185&#x2013;192. doi: 10.1007/s11684-020-0754-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11684-020-0754-0</ArticleId><ArticleId IdType="pmc">PMC7088738</ArticleId><ArticleId IdType="pubmed">32170560</ArticleId></ArticleIdList></Reference><Reference><Citation>Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417&#x2013;1418. doi: 10.1016/S0140-6736(20)30937-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30937-5</ArticleId><ArticleId IdType="pmc">PMC7172722</ArticleId><ArticleId IdType="pubmed">32325026</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Gemelli against COVID-19 post-acute care study group. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al. ARC Study Group (2021) 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax 76(4):396&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Jennings G, Monaghan A, Xue F, et al. A systematic review of persistent symptoms and residual abnormal functioning following acute COVID-19: ongoing symptomatic phase vs. post-COVID-19 syndrome. J Clin Med. 2021;10(24):5913. doi: 10.3390/jcm10245913.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10245913</ArticleId><ArticleId IdType="pmc">PMC8708187</ArticleId><ArticleId IdType="pubmed">34945213</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence (NICE) (2020), Royal College of General Practitioners, Healthcare Improvement Scotland SIGN. COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. National Institute for Health and Care Excellence; London, UK. Accessed on 30 December 2020. Available online: www.nice.org.uk/guidance/ng188</Citation></Reference><Reference><Citation>Baig AM. Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-haulers. J Med Virol. 2021;93(5):2555&#x2013;2556. doi: 10.1002/jmv.26624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26624</ArticleId><ArticleId IdType="pubmed">33095459</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, et al. Defining post-COVID symptoms (post-acute COVID, Long COVID, persistent post-COVID): an integrative classification. Int J Environ Res Public Health. 2021;18(5):2621. doi: 10.3390/ijerph18052621.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph18052621</ArticleId><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Duarte &#xc1;, Rivera-Izquierdo M, Guerrero-Fern&#xe1;ndez de Alba I, et al. Sequelae, persistent symptomatology and outcomes after COVID-19 hospitalization: the ANCOHVID multicentre 6-month follow-up study. BMC Med. 2021;19(1):129. doi: 10.1186/s12916-021-02003-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-021-02003-7</ArticleId><ArticleId IdType="pmc">PMC8134820</ArticleId><ArticleId IdType="pubmed">34011359</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dowds J, O'Brien K, et al. Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity. Ann Am Thorac Soc. 2021;18(6):997&#x2013;1003. doi: 10.1513/AnnalsATS.202009-1175OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202009-1175OC</ArticleId><ArticleId IdType="pmc">PMC8456724</ArticleId><ArticleId IdType="pubmed">33413026</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, et al. Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract. 2022;39(1):159&#x2013;167. doi: 10.1093/fampra/cmab076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Martin E, Garcia-Campayo J, Puebla-Guedea M, et al. Fibromyalgia is correlated with retinal nerve fiber layer thinning. PLoS One. 2016;11(9):e0161574. doi: 10.1371/journal.pone.0161574.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0161574</ArticleId><ArticleId IdType="pmc">PMC5008644</ArticleId><ArticleId IdType="pubmed">27584145</ArticleId></ArticleIdList></Reference><Reference><Citation>Invernizzi A, Agarwal AK, Ravera V, et al. Comparing optical coherence tomography findings in different aetiologies of infectious necrotising retinitis. Br J Ophthalmol. 2018;102(4):433&#x2013;437. doi: 10.1136/bjophthalmol-2017-310210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2017-310210</ArticleId><ArticleId IdType="pubmed">28765144</ArticleId></ArticleIdList></Reference><Reference><Citation>Grading diabetic retinopathy from stereoscopic color (1991) Fundus photographs&#x2014;an extension of the modified Airlie House classification. ETDRS reportnumber 10. Early treatment diabetic retinopathy study research group. Ophthalmology 98:786&#x2013;806</Citation><ArticleIdList><ArticleId IdType="pubmed">2062513</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilbao-Malav&#xe9; V, Gonz&#xe1;lez-Zamora J, Saenz de Viteri M, et al. Persistent retinal microvascular &#x131;mpairment in COVID-19 bilateral pneumonia at 6-months follow-up assessed by optical coherence tomography angiography. Biomedicines. 2021;9(5):502. doi: 10.3390/biomedicines9050502.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9050502</ArticleId><ArticleId IdType="pmc">PMC8147391</ArticleId><ArticleId IdType="pubmed">34063291</ArticleId></ArticleIdList></Reference><Reference><Citation>Lederer DE, Schuman JS, Hertzmark E, et al. Analysis of macular volume in normal and glaucomatous eyes using optical coherence tomography. Am J Ophthalmol. 2003;135(6):838&#x2013;43. doi: 10.1016/S0002-9394(02)02277-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9394(02)02277-8</ArticleId><ArticleId IdType="pubmed">12788124</ArticleId></ArticleIdList></Reference><Reference><Citation>Medeiros FA, Zangwill LM, Bowd C, et al. Evaluation of retinal nerve fiber layer, optic nerve head, and macular thickness measurements for glaucoma detection using optical coherence tomography. Am J Ophthalmol. 2005;139(1):44&#x2013;55. doi: 10.1016/j.ajo.2004.08.069.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajo.2004.08.069</ArticleId><ArticleId IdType="pubmed">15652827</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung CY, Ikram MK, Chen C, et al. Imaging retina to study dementia and stroke. Prog Retin Eye Res. 2017;57:89&#x2013;107. doi: 10.1016/j.preteyeres.2017.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.preteyeres.2017.01.001</ArticleId><ArticleId IdType="pubmed">28057562</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutlu U, Bonnemaijer PWM, Ikram MA, et al. Retinal neurodegeneration and brain MRI markers: the Rotterdam Study. Neurobiol Aging. 2017;60:183&#x2013;191. doi: 10.1016/j.neurobiolaging.2017.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.09.003</ArticleId><ArticleId IdType="pubmed">28974335</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagu P, Parashar A, Behl T, et al. CNS implications of COVID-19: a comprehensive review. Rev Neurosci. 2020;32(2):219&#x2013;234. doi: 10.1515/revneuro-2020-0070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2020-0070</ArticleId><ArticleId IdType="pubmed">33550782</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferini-Strambi L, Salsone M. COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable? J Neurol. 2021;268(2):409&#x2013;419. doi: 10.1007/s00415-020-10070-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-10070-8</ArticleId><ArticleId IdType="pmc">PMC7372546</ArticleId><ArticleId IdType="pubmed">32696341</ArticleId></ArticleIdList></Reference><Reference><Citation>Teo KY, Invernizzi A, Staurenghi G, et al. COVID-19-related retinal micro-vasculopathy&#x2014;a review of current evidence. Am J Ophthalmol. 2021;235:98&#x2013;110. doi: 10.1016/j.ajo.2021.09.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajo.2021.09.019</ArticleId><ArticleId IdType="pmc">PMC8465265</ArticleId><ArticleId IdType="pubmed">34587494</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins V, Sohaei D, Diamandis EP, et al. COVID-19: from an acute to chronic disease? Potential long-term health consequences. Crit Rev Clin Lab Sci. 2021;58(5):297&#x2013;310. doi: 10.1080/10408363.2020.1860895.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10408363.2020.1860895</ArticleId><ArticleId IdType="pubmed">33347790</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa &#xcd;F, Bonif&#xe1;cio LP, Bellissimo-Rodrigues F, et al. Ocular findings among patients surviving COVID-19. Sci Rep. 2021;11(1):11085. doi: 10.1038/s41598-021-90482-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-90482-2</ArticleId><ArticleId IdType="pmc">PMC8155146</ArticleId><ArticleId IdType="pubmed">34040094</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrishami M, Hassanpour K, Hosseini S, et al. Macular vessel density reduction in patients recovered from COVID-19: a longitudinal optical coherence tomography angiography study. Graefes Arch Clin Exp Ophthalmol. 2021;12:1&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8505785</ArticleId><ArticleId IdType="pubmed">34636996</ArticleId></ArticleIdList></Reference><Reference><Citation>Turker IC, Dogan CU, Guven D, et al. Optical coherence tomography angiography findings in patients with COVID-19. Can J Ophthalmol. 2021;56(2):83&#x2013;87. doi: 10.1016/j.jcjo.2020.12.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcjo.2020.12.021</ArticleId><ArticleId IdType="pmc">PMC7833266</ArticleId><ArticleId IdType="pubmed">33497612</ArticleId></ArticleIdList></Reference><Reference><Citation>Zapata M&#xc1;, Banderas Garc&#xed;a S, S&#xe1;nchez-Moltalv&#xe1; A, et al. Retinal microvascular abnormalities in patients after COVID-19 depending on disease severity. Br J Ophthalmol. 2022;106(4):559&#x2013;563. doi: 10.1136/bjophthalmol-2020-317953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2020-317953</ArticleId><ArticleId IdType="pubmed">33328184</ArticleId></ArticleIdList></Reference><Reference><Citation>Virgo J, Mohamed M. Paracentral acute middle maculopathy and acute macular neuroretinopathy following SARS-CoV-2 infection. Eye (Lond) 2020;34:2352&#x2013;3. doi: 10.1038/s41433-020-1069-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41433-020-1069-8</ArticleId><ArticleId IdType="pmc">PMC7333786</ArticleId><ArticleId IdType="pubmed">32620843</ArticleId></ArticleIdList></Reference><Reference><Citation>Casagrande M, Fitzek A, Puschel K, et al. Detection of SARS-CoV-2 in human retinal biopsies of deceased COVID-19 patients. Ocul Immunol Inflamm. 2020;28:721&#x2013;5. doi: 10.1080/09273948.2020.1770301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09273948.2020.1770301</ArticleId><ArticleId IdType="pubmed">32469258</ArticleId></ArticleIdList></Reference><Reference><Citation>ZagoFilho LA, Lima LH, Melo GB, et al. Vitritis and outer retinal abnormalities in a patient with COVID19. Ocul Immunol Inflamm. 2020;28:1&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">33021846</ArticleId></ArticleIdList></Reference><Reference><Citation>Araujo-Silva CA, Marcos AAA, Marinho PM, et al. Presumed SARS-CoV-2 viral particles in the human retina of patients with COVID-19. JAMA Ophthalmol. 2021;139(9):1015&#x2013;1021. doi: 10.1001/jamaophthalmol.2021.2795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaophthalmol.2021.2795</ArticleId><ArticleId IdType="pmc">PMC8323055</ArticleId><ArticleId IdType="pubmed">34323931</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalugo M, Schulte LJ, Masood MF, et al. Microvascular angiopathic consequences of COVID 19. Front Cardiovasc. Med. 2021;8:26. doi: 10.3389/fcvm.2021.636843.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.636843</ArticleId><ArticleId IdType="pmc">PMC7884319</ArticleId><ArticleId IdType="pubmed">33604359</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschauer J, Pollreisz A, Karst S, et al. Longitudinal analysis of microvascular perfusion and neurodegenerative changes in early type 2 diabetic retinal disease. Br J Ophthalmol. 2020;106:528&#x2013;533. doi: 10.1136/bjophthalmol-2020-317322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjophthalmol-2020-317322</ArticleId><ArticleId IdType="pubmed">33293271</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambiya V, Kumar A, Bhavaraj VR, et al. Study of inner retinal neurodegeneration in diabetes mellitus using spectral domain optical coherence tomography. Eur J Ophthalmol. 2021;30:11206721211048793.</Citation><ArticleIdList><ArticleId IdType="pubmed">34590491</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Martin E, Cipres M, Melchor I, et al. Neurodegeneration in patients with Type 2 diabetes mellitus without diabetic retinopathy. J Ophthalmol. 2019;2019:1825819. doi: 10.1155/2019/1825819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/1825819</ArticleId><ArticleId IdType="pmc">PMC6702840</ArticleId><ArticleId IdType="pubmed">31485340</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>